Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
In vitro gene mutation study in bacteria
In the key study, the following strains were tested with and without the presence of metabolic activation by S9-mix: TA 1535, TA 1537, TA 98, TA 100 and WP2uvrA. Positive and solvent controls were run concurrently. Two separate assays were performed as part of this study, both yielding similar results. No mutagenic response was observed in any of the five strains tested in either the presence or absence of metabolic activation up to a maximum concentration of 10,000 µg per plate; furthermore, no cytotoxicity was observed. Test material precipitate was observed on the plates at concentrations of 1000 µg per plate and above. Positive controls demonstrated the sensitivity of the assay and the metabolising activity of the S9 mix and all results were considered to be valid.
In the supporting study, the following strains were tested with and without the presence of metabolic activation by S9-mix: TA 1535, TA 1537, TA 98 and TA 100. Both the concurrent positive and solvent controls were valid, demonstrating the sensitivity of the assay and the metabolising activity of the S9-mix. There was no substantial increase in revertant colony numbers for any of the tester strains. However considerable test variability was encountered with the test material due to a variable chemical reaction, upon incubation at 37 ºC, between the test material and the agar at the higher test concentrations. This reaction produced a white material, resembling microbial contamination which obscured the evaluation of mutagenic potential at high concentrations. Under the specific conditions of the test, the test material is considered to have given a negative response.
Both of the studies available for this endpoint showed no evidence of the test material being mutagenic.
In vitro cytogenicity
A micronucleus assay was conducted in the key study with the test material suspended in peanut oil and dosed by intraperitoneal injection at 1250, 2500 and 5000 mg/kg. Ten animals (five males and five females) were assigned to each dose/harvest time group. The animals dosed with the test material and vehicle control were sacrificed approximately 24, 48 and 72 hours after dosing for extraction of the femur bone marrow. The animals dosed with the positive control were sacrificed approximately 24 hours after dosing for extraction of the bone marrow. The test material induced no statistically significant increase in micronucleated polychromatic erythrocytes over the levels observed in the vehicle controls in either sex or at any of the harvest times. A statistically significant decrease in the PCE:NCE ratio was observed in the 5000 mg/kg females at the 72 hour harvest time. Under the conditions of the assay, the test material did not induce a statistically significant increase in micronuclei and was considered negative in the mouse micronucleus assay.
Justification for selection of genetic toxicity endpoint
No single study could not be selected, as all studies are necessary in assessing the genotoxic potential of the test substance.
Short description of key information:
IN VITRO GENE MUATION STUDY IN BACTERIA
Orthoboric acid, potassium salt was determined to be negative in an Ames study performed in accordance with OECD 471, EU Method B13/14, EPA OPPTS 870.5100 and MOHW (Pharmaceutical Affairs Bureau Notification No. 24). This was confirmed in a supporting Ames study considered to be equivalent or similar to OCED 471.
IN VIVO CYTOGENICITY IN MAMMALIAN CELLS
Orthoboric acid, potassium salt was determined to be negative in a mouse micronucleus study performed in accordance with EPA OPPTS 870.5395.
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
In accordance with the criteria for classification as defined in Regulation 1272/2008 and Directive /548/EEC, the substance does not require classification for genotoxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.